Ep. 75: Catherine Wood: Tesla Leads These Tech Stocks Surging Higher As Innovations Accelerate
Investing With IBD
00:00
The Evolution of Genetics in the World of Artificial Intelligence
We own some tech companies in here. Not too many. I mean, it is predominantly genomics companies. But the convergence of artificial intelligence, DNA sequencing, and CRISPR gene editing is going to power other companies as well. We think Invite could be that company in the molecular diagnostic space,. especially now that they just bought a liquid biopsy company.
Transcript
Play full episode
